Brenda Libby Coleman

Array ( [id] => 5694773 [patent_doc_number] => 20060154920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => '1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents' [patent_app_type] => utility [patent_app_number] => 11/377489 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9878 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154920.pdf [firstpage_image] =>[orig_patent_app_number] => 11377489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6389969 [patent_doc_number] => 20100317849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Process For Producing Pure And Stable Form Of 2-Methyl-4-(4-Methyl-1-Piperazinyl) -10H-Thieno[2,3-B] [1,5] Benzodiazepine' [patent_app_type] => utility [patent_app_number] => 12/225080 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4412 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317849.pdf [firstpage_image] =>[orig_patent_app_number] => 12225080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960598 [patent_doc_number] => 20080275023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations' [patent_app_type] => utility [patent_app_number] => 11/886168 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10462 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275023.pdf [firstpage_image] =>[orig_patent_app_number] => 11886168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753214 [patent_doc_number] => 20080161289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Fused Thiazole Derivatives Having Affinity for the Histamine H3 Receptor' [patent_app_type] => utility [patent_app_number] => 11/908532 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33025 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161289.pdf [firstpage_image] =>[orig_patent_app_number] => 11908532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274289 [patent_doc_number] => 07560454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Condensed azepines as vasopressin agonists' [patent_app_type] => utility [patent_app_number] => 11/370861 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7147 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560454.pdf [firstpage_image] =>[orig_patent_app_number] => 11370861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432332 [patent_doc_number] => 07265105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Pyrrolobenzodiazepines' [patent_app_type] => utility [patent_app_number] => 11/367241 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33578 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265105.pdf [firstpage_image] =>[orig_patent_app_number] => 11367241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142119 [patent_doc_number] => 07691848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/365035 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26924 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691848.pdf [firstpage_image] =>[orig_patent_app_number] => 11365035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375828 [patent_doc_number] => 08680092 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Nitrogenous heterocyclic compound and medicinal use thereof' [patent_app_type] => utility [patent_app_number] => 11/816940 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50470 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11816940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 415388 [patent_doc_number] => 07279573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Amide derivatives' [patent_app_type] => utility [patent_app_number] => 11/359616 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29227 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279573.pdf [firstpage_image] =>[orig_patent_app_number] => 11359616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656532 [patent_doc_number] => 20060142268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => '1,4,5,6-tetrahydroimidazo[4,5-d]benzazepine derivative or salt thereof' [patent_app_type] => utility [patent_app_number] => 11/353995 [patent_app_country] => US [patent_app_date] => 2006-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9453 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142268.pdf [firstpage_image] =>[orig_patent_app_number] => 11353995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 872387 [patent_doc_number] => 07361656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-22 [patent_title] => 'Prenyl transferase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/353518 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23306 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/361/07361656.pdf [firstpage_image] =>[orig_patent_app_number] => 11353518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324272 [patent_doc_number] => 20090062262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'NON STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 11/816113 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14107 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062262.pdf [firstpage_image] =>[orig_patent_app_number] => 11816113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112746 [patent_doc_number] => 07713969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Compositions and methods for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/350335 [patent_app_country] => US [patent_app_date] => 2006-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 47920 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713969.pdf [firstpage_image] =>[orig_patent_app_number] => 11350335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833942 [patent_doc_number] => 20080132489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Novel Alkyl Substituted Homopiperazine Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/795768 [patent_app_country] => US [patent_app_date] => 2006-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5956 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132489.pdf [firstpage_image] =>[orig_patent_app_number] => 11795768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5160452 [patent_doc_number] => 20070173496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Novel polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E' [patent_app_type] => utility [patent_app_number] => 11/340284 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7208 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173496.pdf [firstpage_image] =>[orig_patent_app_number] => 11340284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92266 [patent_doc_number] => 07737142 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => '(Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/337275 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7638 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737142.pdf [firstpage_image] =>[orig_patent_app_number] => 11337275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786478 [patent_doc_number] => 20080139807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Method For Preparation Of 10,11-Dihydro-10-Hydroxy-5H-Dibenz/B,F/Azepine-5-Carboxamide' [patent_app_type] => utility [patent_app_number] => 11/813938 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4126 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139807.pdf [firstpage_image] =>[orig_patent_app_number] => 11813938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 577873 [patent_doc_number] => 07456172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Succinoylamino benzodiazepines as inhibitors of Aβ protein production' [patent_app_type] => utility [patent_app_number] => 11/331791 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44345 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456172.pdf [firstpage_image] =>[orig_patent_app_number] => 11331791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274288 [patent_doc_number] => 07560453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => '6-(2, 3, 4, 5-tetrahydro-1H-benzo [D] azepin-7-yloxy) -nicotamide derivatives as radio labelled ligands' [patent_app_type] => utility [patent_app_number] => 11/813357 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2928 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560453.pdf [firstpage_image] =>[orig_patent_app_number] => 11813357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813908 [patent_doc_number] => 20080194539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Phenyl Diazepane Carboxamides and Annelated Phenyl Piperazine Carboxamides Containing Oxygen and Used as Dopamine D3 Antagonists' [patent_app_type] => utility [patent_app_number] => 11/794386 [patent_app_country] => US [patent_app_date] => 2005-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29743 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194539.pdf [firstpage_image] =>[orig_patent_app_number] => 11794386 [rel_patent_id] =>[rel_patent_doc_number] =>)